{"entity":{"type":"insider","cik":"0001308803","url":"/insider/0001308803","json_url":"/insider/0001308803.json","name":"Eidell Ronald G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2005-02-11","last":"2006-01-06","span_basis":"filed_date"},"name_variants":[{"name":"Eidell Ronald G","source":"filing","n_filings":3,"first_seen":"2005-02-11","last_seen":"2006-01-06"}],"transactions":[{"id":4077125,"accession":"0001104659-06-000932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-06-000932","line_url":"/filing/0001104659-06-000932#line-1","is_derivative":false,"issuer_cik":"0000942788","issuer_name":"NEOPHARM INC","issuer_ticker":"NEOL","issuer_name_source":null,"issuer_url":"/issuer/0000942788","owner_cik":"0001308803","owner_name":"Eidell Ronald G","owner_display_name":"Eidell Ronald G","owner_url":"/insider/0001308803","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4900.0,"shares_display":"4,900","price_per_share":10.2,"price_display":"10.20","price_state":"stated","total_value":49980.0,"total_display":"49,980.00","total_whole":"49,980","shares_owned_after":13992.0,"shares_owned_after_display":"13,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-01-05","filed_date":"2006-01-06","scope":"insider"},{"id":1603818,"accession":"0001104659-05-010924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-05-010924","line_url":"/filing/0001104659-05-010924#line-1","is_derivative":false,"issuer_cik":"0000942788","issuer_name":"NEOPHARM INC","issuer_ticker":"NEOL","issuer_name_source":null,"issuer_url":"/issuer/0000942788","owner_cik":"0001308803","owner_name":"Eidell Ronald G","owner_display_name":"Eidell Ronald G","owner_url":"/insider/0001308803","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":5600.0,"shares_owned_after_display":"5,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-11","filed_date":"2005-03-14","scope":"insider"},{"id":1276343,"accession":"0001104659-05-005655","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-05-005655","line_url":"/filing/0001104659-05-005655#line-1","is_derivative":false,"issuer_cik":"0000942788","issuer_name":"NEOPHARM INC","issuer_ticker":"NEOL","issuer_name_source":null,"issuer_url":"/issuer/0000942788","owner_cik":"0001308803","owner_name":"Eidell Ronald G","owner_display_name":"Eidell Ronald G","owner_url":"/insider/0001308803","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":11.95,"price_display":"11.95","price_state":"stated","total_value":25095.0,"total_display":"25,095.00","total_whole":"25,095","shares_owned_after":4600.0,"shares_owned_after_display":"4,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-09","filed_date":"2005-02-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000942788","name":"NEOPHARM INC","url":"/issuer/0000942788","role":"Director, Officer (President and CEO)","n_filings":3,"first_seen":"2005-02-11","last_seen":"2006-01-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001308803","retrieved_at":"2026-08-24T00:44:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}